Search - tctmd.com

Displaying 261 - 280 of 341

Sort: Relevancy | Date

Presentation TCT 2015

Updated Meta-analysis of Culprit Only vs Complete Revascularization in STEMI: Are We Impacting Death and Reinfarction or Repeat Revascularization Only?

Presenter: Thomas Engstroem, Barry D. Rutherford, Anthony H. Gershlick

October 11, 2015

Presentation TCT 2015

Introduction: A Critical Appraisal of Culprit Only vs Multivessel Intervention in STEMI Targets, Guidance, Data Review, and Future Directions

Presenter: Thomas Engstroem, Barry D. Rutherford, Shamir R. Mehta

October 11, 2015

News Conference News TCT 2015

FFR Guidance Could Reduce Need for Multivessel Primary PCI

October 11, 2015

News Features TCT 2014

Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease

Todd Neale

October 24, 2014

News Conference News TCT 2014

Thoughtful Insights at TCT: Dealing With Complex CAD Cases

Todd Neale

October 17, 2014

News Conference News TCT 2014

I-LOVE-IT 2: Biodegradable Polymer SES as Effective as Durable Polymer SES in All-Comers

September 17, 2014

Presentation TCT 2014

Managing Multivessel Disease in STEMI: From PRAMI to CVLPRIT

Presenter: Francisco Fdez-Aviles, Abhiram Prasad, Anthony H. Gershlick

September 16, 2014

Presentation TCT 2014

Case Conclusion: A Diabetic Patient with Double Vessel Coronary Artery Disease How Did I Treat?

Presenter: George D. Dangas, Michael E. Farkouh, Manish A. Parikh

September 16, 2014

Presentation TCT 2014

Chronic Renal Failure: An Emerging Important Risk Modifier in Patients with Multivessel CAD with and without Diabetes?

Presenter: George D. Dangas, Michael E. Farkouh, Usman Baber

September 16, 2014

Presentation TCT 2014

The Case for CABG in Most Patients with Multivessel Disease with and without Diabetes

Presenter: George D. Dangas, Michael E. Farkouh, John D. Puskas

September 16, 2014

Presentation TCT 2014

The Case for PCI in Most Patients with Multivessel Disease with and without Diabetes

Presenter: George D. Dangas, Michael E. Farkouh, Frederick Feit

September 16, 2014

Presentation TCT 2014

Con: The Guidelines are Appropriately Conservative!

Presenter: Adrian P. Banning, Nick Curzen

September 16, 2014

Presentation TCT 2014

The Case for Medical Therapy without Revascularization in Most Patients with and without Diabetes

Presenter: George D. Dangas, Michael E. Farkouh, David J. Maron

September 16, 2014

Presentation TCT 2014

Pro: The Guidelines are Antiquated!

Presenter: Adrian P. Banning, Cindy L. Grines

September 16, 2014

Presentation TCT 2014

Case Introduction: A Diabetic Patient with Double Vessel Coronary Artery Disease How Should We Treat?

Presenter: George D. Dangas, Michael E. Farkouh, Manish A. Parikh

September 16, 2014

Presentation TCT 2014

Case #2: ACS, Multivessel Disease, and an Uncertain Target Lesion

Presenter: Matjaz Bunc, Ariel Finkelstein, Susheel Kodali, Georgios Sianos, Miha Cercek

September 16, 2014

Presentation TCT 2014

Preventive versus Culprit Only Percutaneous Coronary Intervention in ST Elevation Myocardial Infarction Patients with Multivessel Disease: A Meta Analysis

Presenter: Yeo-Jeong Song

September 16, 2014

News Conference News TCT 2014

Keynote Address Focuses on Newer DES, Problematic Subgroups

September 15, 2014

Presentation TCT 2014

TCT 14: Preventive Versus Culprit-Only Percutaneous Coronary Intervention in ST Elevation Myocardial Infarction Patients with Multivessel Disease: A Meta-analysis

Presenter: Yeo-Jeong Song, MD

September 14, 2014

Presentation TCT 2014

SMILE: A Prospective, Randomized Trial of Single-Staged Versus Multistaged Coronary Intervention in Patients with NonST-Segment Elevation Myocardial Infarction and Multivessel Disease

Presenter: Steven R. Bailey, Gennaro Sardella

September 14, 2014

Advertisement

Updated Meta-analysis of Culprit Only vs Complete Revascularization in STEMI: Are We Impacting Death and Reinfarction or Repeat Revascularization Only?

Introduction: A Critical Appraisal of Culprit Only vs Multivessel Intervention in STEMI Targets, Guidance, Data Review, and Future Directions

FFR Guidance Could Reduce Need for Multivessel Primary PCI

Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease

Thoughtful Insights at TCT: Dealing With Complex CAD Cases

I-LOVE-IT 2: Biodegradable Polymer SES as Effective as Durable Polymer SES in All-Comers

Managing Multivessel Disease in STEMI: From PRAMI to CVLPRIT

Case Conclusion: A Diabetic Patient with Double Vessel Coronary Artery Disease How Did I Treat?

Chronic Renal Failure: An Emerging Important Risk Modifier in Patients with Multivessel CAD with and without Diabetes?

The Case for CABG in Most Patients with Multivessel Disease with and without Diabetes

The Case for PCI in Most Patients with Multivessel Disease with and without Diabetes

Con: The Guidelines are Appropriately Conservative!

The Case for Medical Therapy without Revascularization in Most Patients with and without Diabetes

Pro: The Guidelines are Antiquated!

Case Introduction: A Diabetic Patient with Double Vessel Coronary Artery Disease How Should We Treat?

Case #2: ACS, Multivessel Disease, and an Uncertain Target Lesion

Preventive versus Culprit Only Percutaneous Coronary Intervention in ST Elevation Myocardial Infarction Patients with Multivessel Disease: A Meta Analysis

Keynote Address Focuses on Newer DES, Problematic Subgroups

TCT 14: Preventive Versus Culprit-Only Percutaneous Coronary Intervention in ST Elevation Myocardial Infarction Patients with Multivessel Disease: A Meta-analysis

SMILE: A Prospective, Randomized Trial of Single-Staged Versus Multistaged Coronary Intervention in Patients with NonST-Segment Elevation Myocardial Infarction and Multivessel Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content